BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17549441)

  • 61. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
    Kleer CG; Zhang Y; Pan Q; Gallagher G; Wu M; Wu ZF; Merajver SD
    Breast Cancer Res; 2004; 6(1):R110-5. PubMed ID: 14696649
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of DCP1a in gastric cancer and its biological function and mechanism in chemotherapy resistance in gastric cancer cells.
    Ruan T; Zhang Y; Liu W; Li Y; Wang D; Du Z; Tao K; Wu C
    Dig Liver Dis; 2020 Nov; 52(11):1351-1358. PubMed ID: 32646734
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
    Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
    Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression and significance of RhoC gene in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Huang GW; Lu WQ
    World J Gastroenterol; 2003 Sep; 9(9):1950-3. PubMed ID: 12970882
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Knockdown of MTDH/AEG-1 inhibits the growth and metastasis of SGC7901 cells].
    Yu H; Jiang L; Zhou K; Wang X; Liu B; Zheng Y; Zeng J; Xiao F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1234-1239. PubMed ID: 29089083
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.
    Yao H; Dashner EJ; van Golen CM; van Golen KL
    Oncogene; 2006 Apr; 25(16):2285-96. PubMed ID: 16314838
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RhoE promotes metastasis in gastric cancer through a mechanism dependent on enhanced expression of CXCR4.
    Feng B; Li K; Zhong H; Ren G; Wang H; Shang Y; Bai M; Liang J; Wang X; Fan D
    PLoS One; 2013; 8(11):e81709. PubMed ID: 24312338
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effects of RNA interference silencing RhoC gene upon paclitaxel sensitivity in ovarian cancer cell lines].
    Pan Y; Zhang WY; Zou JY; Sheng MJ; Xuan LL; Hai DY
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(21):1498-501. PubMed ID: 19953905
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cells.
    Li NF; Gemenetzidis E; Marshall FJ; Davies D; Yu Y; Frese K; Froeling FE; Woolf AK; Feakins RM; Naito Y; Iacobuzio-Donahue C; Tuveson DA; Hart IR; Kocher HM
    PLoS One; 2013; 8(12):e81575. PubMed ID: 24312560
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RhoC impacts the metastatic potential and abundance of breast cancer stem cells.
    Rosenthal DT; Zhang J; Bao L; Zhu L; Wu Z; Toy K; Kleer CG; Merajver SD
    PLoS One; 2012; 7(7):e40979. PubMed ID: 22911725
    [TBL] [Abstract][Full Text] [Related]  

  • 74. p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.
    Rosenthal DT; Iyer H; Escudero S; Bao L; Wu Z; Ventura AC; Kleer CG; Arruda EM; Garikipati K; Merajver SD
    Cancer Res; 2011 Oct; 71(20):6338-49. PubMed ID: 21862636
    [TBL] [Abstract][Full Text] [Related]  

  • 75. RhoC and ROCKs regulate cancer cell interactions with endothelial cells.
    Reymond N; Im JH; Garg R; Cox S; Soyer M; Riou P; Colomba A; Muschel RJ; Ridley AJ
    Mol Oncol; 2015 Jun; 9(6):1043-55. PubMed ID: 25677806
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Expression and its relationship of PRL-3 and RhoC in non-small cell lung cancer].
    Zhang P; Zhang Z; Li X; Lei J; Su K; Li X; Wang X
    Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):598-601. PubMed ID: 20681446
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Expressions and significances of PRL-3 and RhoC in A549 cell].
    ZHANG P; ZHANG Z; LI X; LEI J; SU K; LI X; WANG X
    Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1160-4. PubMed ID: 21159255
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase.
    Hall CL; Dubyk CW; Riesenberger TA; Shein D; Keller ET; van Golen KL
    Neoplasia; 2008 Aug; 10(8):797-803. PubMed ID: 18670640
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The interaction of PKN3 with RhoC promotes malignant growth.
    Unsal-Kacmaz K; Ragunathan S; Rosfjord E; Dann S; Upeslacis E; Grillo M; Hernandez R; Mack F; Klippel A
    Mol Oncol; 2012 Jun; 6(3):284-98. PubMed ID: 22217540
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Specific role of RhoC in tumor invasion and metastasis.
    Lang S; Busch H; Boerries M; Brummer T; Timme S; Lassmann S; Aktories K; Schmidt G
    Oncotarget; 2017 Oct; 8(50):87364-87378. PubMed ID: 29152087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.